ELDN Earnings

Quarterly EPS
$1.05
Q3 2024
$-0.60
Q4 2024
$-0.08
Q1 2025
$-0.13
Q2 2025
$-0.21
Q3 2025
$-0.14
Q4 2025
$-0.33
Q1 2026
$-0.27
Q2 2026
Latest RevenueN/A
Latest Net Income-31630000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.270-31630000-107.7%
Q1 2026-$0.330-39025000-312.5%
Q4 2025-$0.140-10447000+76.7%
Q3 2025-$0.210-17459000-120.0%
Q2 2025-$0.130-11216000+85.9%
Q1 2025-$0.080-6495000+76.5%
Q4 2024-$0.600-44617000+40.0%
Q3 2024$1.05077.0M+418.2%
Q2 2024-$0.920-44907000
Q1 2024-$0.340-10869000
Q4 2023-$1.000-30099000
Q3 2023-$0.330-9906000
Eledon Pharmaceuticals (ELDN) — Earnings